{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Dibenzepin  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Dibenzepin. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Dibenzepin  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "dibenzepin",
    "trial_2_text": "Dibenzepin  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Dibenzepin Supplement: 60 participants will take Dibenzepin 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Dibenzepin. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Dibenzepin  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.21850773692131042,
      "78": 0.18798698484897614,
      "68": 0.1611173003911972,
      "49": 0.15823210775852203,
      "9": 0.15672317147254944,
      "189": 0.15057776868343353,
      "46": 0.14938122034072876,
      "123": 0.14794647693634033,
      "17": 0.14314508438110352,
      "173": 0.1420324593782425,
      "21": 0.1392596811056137,
      "177": 0.13624334335327148,
      "188": 0.13469406962394714,
      "77": 0.12942995131015778,
      "14": 0.1275971382856369,
      "37": 0.12295494228601456,
      "79": 0.11925677955150604,
      "67": 0.1112632229924202,
      "20": 0.10967157036066055,
      "114": 0.10543155670166016,
      "64": 0.09666716307401657,
      "2": 0.09510708600282669,
      "200": 0.09380941838026047,
      "350": 0.09139730781316757,
      "228": 0.08915145695209503,
      "104": 0.08822726458311081,
      "101": 0.07922442257404327,
      "76": 0.07826484739780426,
      "5": 0.07777432352304459,
      "126": 0.07656969875097275,
      "85": 0.07585453242063522,
      "30": 0.07383111119270325,
      "116": 0.07334718853235245,
      "29": 0.07147286832332611,
      "193": 0.07098626345396042,
      "180": 0.06987819820642471,
      "243": 0.06860438734292984,
      "61": 0.06825955957174301,
      "239": 0.06810073554515839,
      "72": 0.066241554915905,
      "102": 0.06375797092914581,
      "131": 0.0620245561003685,
      "151": 0.060943979769945145,
      "86": 0.06084147095680237,
      "69": 0.059723615646362305,
      "396": 0.05785457044839859,
      "18": 0.057313766330480576,
      "341": 0.05712933838367462,
      "82": 0.056386277079582214,
      "276": 0.05613940581679344,
      "139": 0.05569960176944733,
      "27": 0.05449363589286804,
      "28": 0.053890254348516464,
      "466": 0.053226012736558914,
      "269": 0.05233999341726303,
      "179": 0.05229663476347923,
      "204": 0.051345717161893845,
      "147": 0.05115718021988869,
      "261": 0.049465611577034,
      "211": 0.04875168949365616,
      "422": 0.04873800650238991,
      "97": 0.048425354063510895,
      "191": 0.04819788411259651,
      "194": 0.04812117666006088,
      "38": 0.04634038731455803,
      "253": 0.04613171145319939,
      "441": 0.046112220734357834,
      "92": 0.04453093186020851,
      "262": 0.04449637234210968,
      "282": 0.04384173825383186,
      "98": 0.04354735091328621,
      "186": 0.042612578719854355,
      "144": 0.04239397495985031,
      "454": 0.04168551042675972,
      "164": 0.04153168201446533,
      "75": 0.04049515351653099,
      "153": 0.039945706725120544,
      "122": 0.03990540653467178,
      "456": 0.03960191830992699,
      "394": 0.03942141681909561,
      "130": 0.03930412605404854,
      "35": 0.03914504498243332,
      "199": 0.03883687034249306,
      "355": 0.03858570009469986,
      "1": 0.03650519251823425,
      "508": 0.03646455332636833,
      "234": 0.036383919417858124,
      "11": 0.036275193095207214,
      "96": 0.03621111065149307,
      "33": 0.036057423800230026,
      "286": 0.035881560295820236,
      "108": 0.03455604240298271,
      "268": 0.03432849049568176,
      "382": 0.034097615629434586,
      "371": 0.03394920378923416,
      "221": 0.033911965787410736,
      "15": 0.03387010097503662,
      "132": 0.03354807198047638,
      "66": 0.03334232419729233,
      "94": 0.0332198403775692
    },
    "trial_2_ae": {
      "87": 0.21850773692131042,
      "78": 0.18798698484897614,
      "68": 0.1611173003911972,
      "49": 0.15823210775852203,
      "9": 0.15672317147254944,
      "189": 0.15057776868343353,
      "46": 0.14938122034072876,
      "123": 0.14794647693634033,
      "17": 0.14314508438110352,
      "173": 0.1420324593782425,
      "21": 0.1392596811056137,
      "177": 0.13624334335327148,
      "188": 0.13469406962394714,
      "77": 0.12942995131015778,
      "14": 0.1275971382856369,
      "37": 0.12295494228601456,
      "79": 0.11925677955150604,
      "67": 0.1112632229924202,
      "20": 0.10967157036066055,
      "114": 0.10543155670166016,
      "64": 0.09666716307401657,
      "2": 0.09510708600282669,
      "200": 0.09380941838026047,
      "350": 0.09139730781316757,
      "228": 0.08915145695209503,
      "104": 0.08822726458311081,
      "101": 0.07922442257404327,
      "76": 0.07826484739780426,
      "5": 0.07777432352304459,
      "126": 0.07656969875097275,
      "85": 0.07585453242063522,
      "30": 0.07383111119270325,
      "116": 0.07334718853235245,
      "29": 0.07147286832332611,
      "193": 0.07098626345396042,
      "180": 0.06987819820642471,
      "243": 0.06860438734292984,
      "61": 0.06825955957174301,
      "239": 0.06810073554515839,
      "72": 0.066241554915905,
      "102": 0.06375797092914581,
      "131": 0.0620245561003685,
      "151": 0.060943979769945145,
      "86": 0.06084147095680237,
      "69": 0.059723615646362305,
      "396": 0.05785457044839859,
      "18": 0.057313766330480576,
      "341": 0.05712933838367462,
      "82": 0.056386277079582214,
      "276": 0.05613940581679344,
      "139": 0.05569960176944733,
      "27": 0.05449363589286804,
      "28": 0.053890254348516464,
      "466": 0.053226012736558914,
      "269": 0.05233999341726303,
      "179": 0.05229663476347923,
      "204": 0.051345717161893845,
      "147": 0.05115718021988869,
      "261": 0.049465611577034,
      "211": 0.04875168949365616,
      "422": 0.04873800650238991,
      "97": 0.048425354063510895,
      "191": 0.04819788411259651,
      "194": 0.04812117666006088,
      "38": 0.04634038731455803,
      "253": 0.04613171145319939,
      "441": 0.046112220734357834,
      "92": 0.04453093186020851,
      "262": 0.04449637234210968,
      "282": 0.04384173825383186,
      "98": 0.04354735091328621,
      "186": 0.042612578719854355,
      "144": 0.04239397495985031,
      "454": 0.04168551042675972,
      "164": 0.04153168201446533,
      "75": 0.04049515351653099,
      "153": 0.039945706725120544,
      "122": 0.03990540653467178,
      "456": 0.03960191830992699,
      "394": 0.03942141681909561,
      "130": 0.03930412605404854,
      "35": 0.03914504498243332,
      "199": 0.03883687034249306,
      "355": 0.03858570009469986,
      "1": 0.03650519251823425,
      "508": 0.03646455332636833,
      "234": 0.036383919417858124,
      "11": 0.036275193095207214,
      "96": 0.03621111065149307,
      "33": 0.036057423800230026,
      "286": 0.035881560295820236,
      "108": 0.03455604240298271,
      "268": 0.03432849049568176,
      "382": 0.034097615629434586,
      "371": 0.03394920378923416,
      "221": 0.033911965787410736,
      "15": 0.03387010097503662,
      "132": 0.03354807198047638,
      "66": 0.03334232419729233,
      "94": 0.0332198403775692
    }
  },
  "safety": {
    "trial_1_safety": 0.31084850430488586,
    "trial_2_safety": 0.31084850430488586
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47958096861839294
  }
}